Sean M. Ronnekleiv-Kelly, MD close
Sean M. Ronnekleiv-Kelly, MD

New Patients

Contact the Welcome Center for help choosing a new primary care doctor.

For Referring Physicians

How to refer a patient

Sean M. Ronnekleiv-Kelly, MD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Ronnekleiv-Kelly is an assistant professor in the Department of Human Oncology at the University of Wisconsin School of Medicine and Public Health, Madison WI. He specializes in treating patients with gastrointestinal malignancies and sarcoma with a clinical focus on hepatic, biliary and pancreatic malignancy.

Dr. Ronnekleiv-Kelly’s research focuses on pancreatic cancer. Specifically, to understand the interaction of various cell populations in the pancreatic cancer tumor microenvironment and to identify mechanisms for transforming the immune-permissive environment into an immune-targeting environment using pre-clinical mouse models of pancreatic cancer in conjunction with in-vitro studies to accomplish these goals.


Surgery (General)

Surgical Oncology

Bile Duct Resection

Cancer Surgeons

Gastrointestinal Cancer

Gastrointestinal Cancer (Colon and Rectal, Esophageal, Liver, Pancreatic)

Hepatopancreaticobiliary (HPB) Surgery

Liver Resection

Minimally Invasive Gastrectomy

Pancreatic Resection

Sarcoma Resection

Small Bowel Resection


University Hospital
(608) 263-7502 | (800) 323-8942 | Map
UW Carbone Cancer Center
(608) 263-7502 | (800) 323-8942 | Map
University Hospital
(608) 263-7502 | (800) 323-8942 | Map

UW School of Medicine and Public Health

Department of Surgery

Professional Certifications and Education

Board Certification Surgery

Complex General Surgical Oncology, The Johns Hopkins Hospital, Baltimore, MD

Residency University of Wisconsin Hospital and Clinics, Madison, WI
Medical School University of Colorado Denver School of Medicine, Aurora, CO

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.
PubMed Articles
Moris D Ronnekleiv-Kelly S Kostakis ID Tsilimigras DI Beal EW Papalampros A Dimitroulis D Felekouras E Pawlik TM Operative Results and Oncologic Outcomes of Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Versus Two-Stage Hepatectomy (TSH) in Patients with Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-Analysis. World J Surg . 2018 Mar;42(3):806-815
[PubMed ID: 28798996]
Burkhart RA Javed AA Ronnekleiv-Kelly S Wright MJ Poruk KE Eckhauser F Makary MA Cameron JL Wolfgang CL He J Weiss MJ The use of negative pressure wound therapy to prevent post-operative surgical site infections following pancreaticoduodenectomy. HPB (Oxford) . 2017 Sep;19(9):825-831
[PubMed ID: 28602643]
Moris D Ronnekleiv-Kelly S Rahnemai-Azar AA Felekouras E Dillhoff M Schmidt C Pawlik TM Parenchymal-Sparing Versus Anatomic Liver Resection for Colorectal Liver Metastases: a Systematic Review. J Gastrointest Surg . 2017 Jun;21(6):1076-1085
[PubMed ID: 28364212]
Wilson A Winner M Yahanda A Andreatos N Ronnekleiv-Kelly S Pawlik TM Factors associated with decisional regret among patients undergoing major thoracic and abdominal operations. Surgery . 2017 Apr;161(4):1058-1066
[PubMed ID: 27993362]
Winner M Wilson A Ronnekleiv-Kelly S Smith TJ Pawlik TM A Singular Hope: How the Discussion Around Cancer Surgery Sometimes Fails. Ann Surg Oncol . 2017 Jan;24(1):31-37
[PubMed ID: 27638674]
Andreatos N Ronnekleiv-Kelly S Margonis GA Sasaki K Gani F Amini N Wilson A Pawlik TM From bench to bedside: Clinical implications of KRAS status in patients with colorectal liver metastasis. Surg Oncol . 2016 Sep;25(3):332-8
[PubMed ID: 27566041]
Riordan AM Thomas MK Ronnekleiv-Kelly S Warner T Geiger PG Kennedy GD Utility of micro-ribonucleic acid profile for predicting recurrence of rectal cancer. J Surg Res . 2012 Sep;177(1):87-92
[PubMed ID: 22480843]